Akanda (AKAN) Shares Outstanding (Weighted Average) (2020 - 2025)

Akanda's (AKAN) quarterly Shares Outstanding (Weighted Average) came in at $73.6 million in Q4 2025, up 16.17% YoY from $63.3 million in Q4 2024, and up 15.58% on a QoQ basis from $63.6 million in Q2 2025.

Akanda (AKAN) Shares Outstanding (Weighted Average) (2020 - 2025) Analysis & Trends

Akanda's Shares Outstanding (Weighted Average) history runs 6 years deep, the most recent figure standing at $73.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 16.17% year-over-year to $73.6 million in Q4 2025; TTM through Dec 2025 was $73.6 million, a 16.17% increase from a year earlier, with the FY2025 full-year figure at $73.6 million, up 16.17% from the prior year.
  • Shares Outstanding (Weighted Average) was $73.6 million for Q4 2025 at Akanda, up from $63.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for AKAN reached as high as $73.6 million in Q4 2025 and fell as low as $50188.5 in Q2 2023.
  • A 5-year average of $46.4 million and a median of $51.0 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
  • The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) sank 99.89%; it then jumped 123359.76% in 2024.
  • Tracing AKAN's Shares Outstanding (Weighted Average) over 5 years: stood at $7.3 million in 2021, then soared by 581.32% to $49.4 million in 2022, then rose by 3.21% to $51.0 million in 2023, then climbed by 24.11% to $63.3 million in 2024, then gained by 16.17% to $73.6 million in 2025.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $73.6 million, $63.6 million, and $63.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 100.50 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn 5.11 Bn
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 64.74 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 88.01 Mn
10 Akanda 1.34 Bn 1.34 Bn - 73.56 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 73.56 Mn
Jun 30, 2025 63.64 Mn
Dec 31, 2024 63.32 Mn
Jun 30, 2024 61.96 Mn
Dec 31, 2023 51.02 Mn
Jun 30, 2023 50,188.45
Dec 31, 2022 49.43 Mn
Jun 30, 2022 47.10 Mn
Dec 31, 2021 7.26 Mn
Dec 31, 2020 13.13 Mn